Detection of Minority Resistance during Early HIV-1 Infection: Natural Variation and Spurious Detection rather than Transmission and Evolution of Multiple Viral Variants

被引:79
作者
Gianella, Sara [1 ]
Delport, Wayne [1 ]
Pacold, Mary E. [1 ]
Young, Jason A. [1 ]
Choi, Jun Yong [1 ,3 ]
Little, Susan J. [1 ]
Richman, Douglas D. [1 ,2 ]
Pond, Sergei L. Kosakovsky [1 ]
Smith, Davey M. [1 ,2 ]
机构
[1] Univ Calif San Diego, San Diego, CA 92103 USA
[2] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA
[3] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120752, South Korea
基金
瑞士国家科学基金会; 美国国家卫生研究院;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE INHIBITORS; TRANSMITTED DRUG-RESISTANCE; ACTIVE ANTIRETROVIRAL THERAPY; TREATMENT-NAIVE; SELECTIVE PRESSURE; GENETIC BARRIER; MUTATIONS; POPULATIONS; PREVALENCE;
D O I
10.1128/JVI.02582-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Reports of a high frequency of the transmission of minority viral populations with drug-resistant mutations (DRM) are inconsistent with evidence that HIV-1 infections usually arise from mono-or oligoclonal transmission. We performed ultradeep sequencing (UDS) of partial HIV-1 gag, pol, and env genes from 32 recently infected individuals. We then evaluated overall and per-site diversity levels, selective pressure, sequence reproducibility, and presence of DRM and accessory mutations (AM). To differentiate biologically meaningful mutations from those caused by methodological errors, we obtained multinomial confidence intervals (CI) for the proportion of DRM at each site and fitted a binomial mixture model to determine background error rates for each sample. We then examined the association between detected minority DRM and the virologic failure of first-line antiretroviral therapy (ART). Similar to other studies, we observed increased detection of DRM at low frequencies (average, 0.56%; 95% CI, 0.43 to 0.69; expected UDS error, 0.21 +/- 0.08% mutations/site). For 8 duplicate runs, there was variability in the proportions of minority DRM. There was no indication of increased diversity or selection at DRM sites compared to other sites and no association between minority DRM and AM. There was no correlation between detected minority DRM and clinical failure of first-line ART. It is unlikely that minority viral variants harboring DRM are transmitted and maintained in the recipient host. The majority of low-frequency DRM detected using UDS are likely errors inherent to UDS methodology or a consequence of error-prone HIV-1 replication.
引用
收藏
页码:8359 / 8367
页数:9
相关论文
共 77 条
  • [1] Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants
    Abrahams, M. -R.
    Anderson, J. A.
    Giorgi, E. E.
    Seoighe, C.
    Mlisana, K.
    Ping, L. -H.
    Athreya, G. S.
    Treurnicht, F. K.
    Keele, B. F.
    Wood, N.
    Salazar-Gonzalez, J. F.
    Bhattacharya, T.
    Chu, H.
    Hoffman, I.
    Galvin, S.
    Mapanje, C.
    Kazembe, P.
    Thebus, R.
    Fiscus, S.
    Hide, W.
    Cohen, M. S.
    Karim, S. Abdool
    Haynes, B. F.
    Shaw, G. M.
    Hahn, B. H.
    Korber, B. T.
    Swanstrom, R.
    Williamson, C.
    [J]. JOURNAL OF VIROLOGY, 2009, 83 (08) : 3556 - 3567
  • [2] Aghokeng AF, 2010, ANTIVIR THER, V15, pA151
  • [3] NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION
    AKAIKE, H
    [J]. IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) : 716 - 723
  • [4] Investigating Protein-Coding Sequence Evolution with Probabilistic Codon Substitution Models
    Anisimova, Maria
    Kosiol, Carolin
    [J]. MOLECULAR BIOLOGY AND EVOLUTION, 2009, 26 (02) : 255 - 271
  • [5] Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy
    Bacheler, L
    Jeffrey, S
    Hanna, G
    D'Aquila, R
    Wallace, L
    Logue, K
    Cordova, B
    Hertogs, K
    Larder, B
    Buckery, R
    Baker, D
    Gallagher, K
    Scarnati, H
    Tritch, R
    Rizzo, C
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (11) : 4999 - 5008
  • [6] A novel mutation (F227L) arises in the reverse transcriptase of human immunodeficiency virus type 1 on dose-escalating treatment of HIV type 1-infected cell cultures with the nonnucleoside reverse transcriptase inhibitor thiocarboxanilide UC-781
    Balzarini, J
    Pelemans, H
    Esnouf, R
    De Clercq, E
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (03) : 255 - 260
  • [7] Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users
    Bar, Katharine J.
    Li, Hui
    Chamberland, Annie
    Tremblay, Cecile
    Routy, Jean Pierre
    Grayson, Truman
    Sun, Chuanxi
    Wang, Shuyi
    Learn, Gerald H.
    Morgan, Charity J.
    Schumacher, Joseph E.
    Haynes, Barton F.
    Keele, Brandon F.
    Hahn, Beatrice H.
    Shaw, George M.
    [J]. JOURNAL OF VIROLOGY, 2010, 84 (12) : 6241 - 6247
  • [8] The efficiency of single genome amplification and sequencing is improved by quantitation and use of a bioinformatics tool
    Butler, David M.
    Pacold, Mary E.
    Jordan, Parris S.
    Richman, Douglas D.
    Smith, Davey M.
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2009, 162 (1-2) : 280 - 283
  • [9] HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY
    COFFIN, JM
    [J]. SCIENCE, 1995, 267 (5197) : 483 - 489
  • [10] Solutions for PCR, cloning and sequencing errors in population genetic analysis
    Cummings, S. M.
    McMullan, M.
    Joyce, D. A.
    van Oosterhout, C.
    [J]. CONSERVATION GENETICS, 2010, 11 (03) : 1095 - 1097